InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,446.00
(
2.17%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
82.77
(
0.00%
)
Bitcoin
63,692.89
(
-0.31%
)
Post# of 251720
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 826
Posts 119569
Boards Moderated 14
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 173819

Saturday, 02/08/2014 2:51:20 PM

Saturday, February 08, 2014 2:51:20 PM

Post# of 251720
AGN’s Botox sold at a $2.1B annualized rate in 4Q13, +12% YoY in constant currencies:

http://finance.yahoo.com/news/allergan-reports-fourth-quarter-2013-140000310.html

Medical (i.e. non-cosmetic) Botox indications accounted for 54% of total Botox sales in 2013 and grew faster than Botox sales in cosmetic indications.

AGN’s 2014 guidance calls for Botox sales of $2.18-2.28B and non-GAAP EPS of $1.09-1.12.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up